Search details
1.
Adalimumab in Biologic-naïve Patients With Crohn's Disease After Resolution of an Intra-abdominal Abscess: A Prospective Study From the GETAID.
Clin Gastroenterol Hepatol
; 21(13): 3365-3378.e5, 2023 12.
Article
in English
| MEDLINE | ID: mdl-36731588
2.
Impact of HIV Infection on the Course of Inflammatory Bowel Disease and Drug Safety Profile: A Multicenter GETAID Study.
Clin Gastroenterol Hepatol
; 20(4): 787-797.e2, 2022 04.
Article
in English
| MEDLINE | ID: mdl-33359726
3.
Efficacy and Safety of Infliximab Retreatment in Crohn's Disease: A Multicentre, Prospective, Observational Cohort (REGAIN) Study from the GETAID.
Am J Gastroenterol
; 117(9): 1482-1490, 2022 09 01.
Article
in English
| MEDLINE | ID: mdl-35973142
4.
Comparative real-world effectiveness of vedolizumab and ustekinumab for patients with ulcerative colitis: a GETAID multicentre cohort study.
Scand J Gastroenterol
; 57(12): 1454-1462, 2022 12.
Article
in English
| MEDLINE | ID: mdl-35819361
5.
Efficacy of ustekinumab, vedolizumab, or a second anti-TNF agent after the failure of a first anti-TNF agent in patients with Crohn's disease: a multicentre retrospective study.
BMC Gastroenterol
; 22(1): 498, 2022 Dec 01.
Article
in English
| MEDLINE | ID: mdl-36457080
6.
A Scoring System to Determine Patients' Risk of Colectomy Within 1 Year After Hospital Admission for Acute Severe Ulcerative Colitis.
Clin Gastroenterol Hepatol
; 19(8): 1602-1610.e1, 2021 08.
Article
in English
| MEDLINE | ID: mdl-31927106
7.
Efficacy and Safety of Tumor Necrosis Factor Antagonists in Treatment of Internal Fistulizing Crohn's Disease.
Clin Gastroenterol Hepatol
; 18(3): 628-636, 2020 03.
Article
in English
| MEDLINE | ID: mdl-31128337
8.
Efficacy of Tumor Necrosis Factor Antagonist Treatment in Patients With Refractory Ulcerative Proctitis.
Clin Gastroenterol Hepatol
; 18(3): 620-627.e1, 2020 03.
Article
in English
| MEDLINE | ID: mdl-31202984
9.
Ustekinumab for Perianal Crohn's Disease: The BioLAP Multicenter Study From the GETAID.
Am J Gastroenterol
; 115(11): 1812-1820, 2020 11.
Article
in English
| MEDLINE | ID: mdl-33156100
10.
Outcomes 7 Years After Infliximab Withdrawal for Patients With Crohn's Disease in Sustained Remission.
Clin Gastroenterol Hepatol
; 16(2): 234-243.e2, 2018 02.
Article
in English
| MEDLINE | ID: mdl-28993262
11.
Features of Autoimmune Pancreatitis Associated With Inflammatory Bowel Diseases.
Clin Gastroenterol Hepatol
; 16(1): 59-67, 2018 Jan.
Article
in English
| MEDLINE | ID: mdl-28782667
12.
Correction: Efficacy of ustekinumab, vedolizumab, or a second anti-TNF agent after the failure of a first anti-TNF agent in patients with Crohn's disease: a multicentre retrospective study.
BMC Gastroenterol
; 23(1): 31, 2023 Feb 02.
Article
in English
| MEDLINE | ID: mdl-36732693
13.
Effectiveness and Safety of Vedolizumab Induction Therapy for Patients With Inflammatory Bowel Disease.
Clin Gastroenterol Hepatol
; 14(11): 1593-1601.e2, 2016 11.
Article
in English
| MEDLINE | ID: mdl-26917043
14.
Gastrointestinal bleeding of undetermined origin: What diagnostic strategy to propose?
J Visc Surg
; 160(4): 277-285, 2023 08.
Article
in English
| MEDLINE | ID: mdl-37344277
15.
Risk of SARS-CoV-2 infection in healthcare workers with inflammatory bowel disease: a case-control study.
Infect Prev Pract
; 5(1): 100267, 2023 Mar.
Article
in English
| MEDLINE | ID: mdl-36601289
16.
Comparative Acceptability of Therapeutic Maintenance Regimens in Patients With Inflammatory Bowel Disease: Results From the Nationwide ACCEPT2 Study.
Inflamm Bowel Dis
; 29(4): 579-588, 2023 04 03.
Article
in English
| MEDLINE | ID: mdl-35815744
17.
Withdrawal of infliximab or concomitant immunosuppressant therapy in patients with Crohn's disease on combination therapy (SPARE): a multicentre, open-label, randomised controlled trial.
Lancet Gastroenterol Hepatol
; 8(3): 215-227, 2023 03.
Article
in English
| MEDLINE | ID: mdl-36640794
18.
Obesity in adult patients with inflammatory bowel disease: Clinical features and impact on disability. A cross-sectional survey from the GETAID.
Dig Liver Dis
; 55(12): 1632-1639, 2023 Dec.
Article
in English
| MEDLINE | ID: mdl-37246095
19.
Prevalence and Determinants of Fatigue in Patients with IBD: A Cross-Sectional Survey from the GETAID.
J Crohns Colitis
; 17(9): 1418-1425, 2023 Oct 20.
Article
in English
| MEDLINE | ID: mdl-36988620
20.
Prevalence of anti-TNF contraindications in Crohn's disease: A cross-sectional survey from the GETAID.
Dig Liver Dis
; 54(10): 1350-1357, 2022 10.
Article
in English
| MEDLINE | ID: mdl-35577685